Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters20130801
Title: sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
Journal: Acta physiologica (Oxford, England)20121101
Title: Impact of biological gender and soluble guanylate cyclase stimulation on renal recovery after relief of unilateral ureteral obstruction.
Journal: The Journal of urology20120701
Title: Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension.
Journal: Nitric oxide : biology and chemistry20120630
Title: Pulmonary vascular reserve during experimental pulmonary embolism: effects of a soluble guanylate cyclase stimulator, BAY 41-8543.
Journal: Critical care medicine20111201
Title: Is there a role for soluble guanylate cyclase stimulators in acute pulmonary embolism?
Journal: Critical care medicine20111201
Title: Acidic triazoles as soluble guanylate cyclase stimulators.
Journal: Bioorganic & medicinal chemistry letters20111101
Title: The soluble guanylyl cyclase activator YC-1 increases intracellular cGMP and cAMP via independent mechanisms in INS-1E cells.
Journal: The Journal of pharmacology and experimental therapeutics20110901
Title: Stimulation of soluble guanylate cyclase improves renal recovery after relief of unilateral ureteral obstruction.
Journal: The Journal of urology20110901
Title: Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide.
Journal: American journal of physiology. Heart and circulatory physiology20101001
Title: Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract.
Journal: The journal of sexual medicine20100101
Title: Soluble guanylate cyclase: not a dull enzyme.
Journal: Circulation20090602
Title: Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension.
Journal: ChemMedChem20090501
Title: Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
Journal: The Journal of pharmacology and experimental therapeutics20080801
Title: Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
Journal: American journal of respiratory and critical care medicine20071201
Title: Clinical potential of nitric oxide-independent soluble guanylate cyclase activators.
Journal: Current opinion in investigational drugs (London, England : 2000)20050901
Title: Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase.
Journal: European journal of pharmacology20030516
Title: Metabolites of orally active NO-independent pyrazolopyridine stimulators of soluble guanylate cyclase.
Journal: Bioorganic & medicinal chemistry20020601
Title: Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies.
Journal: British journal of pharmacology20020101
Title: Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vivo studies.
Journal: British journal of pharmacology20020101
Title: Adeleke M Badejo Jr, et al. Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide. Am J Physiol Heart Circ Physiol.
Title: Johannes-Peter Stasch, et al. Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vivo studies. Br J Pharmacol. 2002 Jan;135(2):344-55.
